Savient Pharmaceuticals (SVNT -6%) dips after JMP Securities cuts the shares to Market...

|About: Savient Pharmaceuticals, Inc. (SVNTQ)|By:, SA News Editor

Savient Pharmaceuticals (SVNT -6%) dips after JMP Securities cuts the shares to Market Underperform, citing limited growth potential for the company's gout treatment drug Krystexxa.